Showing 3981-3990 of 4063 results for "".
- Regenxbio Completes Dosing of Fourth Cohort in Phase 1 Trial of RGX-314 Gene Therapy for Wet AMDhttps://modernod.com/news/regenxbio-completes-dosing-of-fourth-cohort-in-phase-1-trial-of-rgx-314-gene-therapy-for-wet-amd/2479815/Regenxbio announced it has completed dosing of the fourth cohort of six patients in a phase 1 clinical trial evaluating RGX-314 for the treatment of wet age-related macular degeneration (AMD). A total of 24 subjects have been dosed in the trial. The company also announced that an updated summary
- Omeros Announces Reinstatement of Pass-Through Status for Omidriahttps://modernod.com/news/omeros-announces-reinstatement-of-pass-through-status-for-omidria/2479831/Omeros announced reinstatement of separate payment by the Centers for Medicare and Medicaid Services (CMS) under the pass-through program for Omidria (phenylephrine and ketorolac intraocular solution) 1%/0.3%. The pass-through status is effective as of October 1, 2018.
- Optovue Showcases First OCT Angiography Metrics and Non-Contact Method for Corneal Measurements at Vision Expo Westhttps://modernod.com/news/optovue-showcases-worlds-first-oct-angiography-metrics-and-non-contact-method-for-corneal-measurements-at-vision-expo-west/2479832/Optovue showcased its AngioAnalytics platform, the world’s first OCT angiography (OCTA) blood vessel measurement technology to help clinicians manage diseases that cause progressive blindness, and 3D PAR, its 3-dimensional projection artifact removal software at Vision Expo West 2018. The
- First FDA-Approved Iris Prosthesis Now Available in the United Stateshttps://modernod.com/news/veo-ophthalmics-launches-customflex-artificialiris-in-the-united-states/2479835/VEO Ophthalmics announced the launch of the ‘Customflex ArtificialIris,’ the first iris prosthesis available in the United States. The surgically implanted device received FDA approval on May 30, 2018 for use in children and adults for the treatment of iris defects resulting from cong
- Neuro-Optometric Rehabilitation Association Names New Members to its Advisory Boardhttps://modernod.com/news/nuero-optometric-rehabilitation-association-names-new-members-to-its-advisory-board/2479836/The Neuro-Optometric Rehabilitation Association, International (NORA) announced the addition of six new members to its Advisory Board, at the Association’s 27th Annual Conference in St. Louis. “Our new Advisory Board members bring a rich mix of backgrounds and experiences that w
- Nicox and Fera Pharmaceuticals to Focus on a Rare Disease Indication for Naproxcinodhttps://modernod.com/news/nicox-and-fera-pharmaceuticals-to-focus-on-a-rare-disease-indication-for-naproxcinod/2479837/Nicox SA and Fera Pharmaceuticals announced that they have amended their 2015 license agreement, which grante
- CMS Proposes to Eliminate Medicare Certification Requirements for Comprehensive H&Ps and Transfer Agreements with Hospitalshttps://modernod.com/news/cms-proposes-to-eliminate-medicare-certification-requirements-for-comprehensive-hps-and-transfer-agreements-with-hospitals/2479844/The Outpatient Ophthalmic Surgery Society (OOSS) issued the following statement in response to recent changes in the Centers for Medicare & Medicaid Services (CMS) Medicare payment policy concerning ambulatory surgery centers (ASCs). “Last week, CMS proposed reducing, modifying,
- Neurolens Appoints Davis Corley Chief Executive Officerhttps://modernod.com/news/neurolens-appoints-davis-corley-chief-executive-officer/2479848/Neurolens announced that its board of directors has named Davis Corley chief executive officer (CEO). Mr. Corley was a co-founder of neurolens in 2012 and has served as president since 2014, a role that he will continue. “Since day one, Davis has led the dev
- Optos Launches Monaco Ultra-Widefield Retinal Imaging Systemhttps://modernod.com/news/optos-launches-monaco-ultra-widefield-retinal-imaging-system/2479855/Optos has launched Monaco, its latest ultra-widefield device to the European ophthalmic market. Monaco is the only ultra-widefield retinal imaging system with integrated Optical Coherence Tomography (OCT), according to Optos. It produces a 200° single-capture optomap image in less than hal
- New 10 Year Warranty for Haag-Streit Slit Lampshttps://modernod.com/news/new-10-year-warranty-for-haag-streit-slit-lamps/2479858/As of October 2018, Haag-Streit Diagnostics is introducing a 10 year limited warranty for its slit lamps. For more information on Haag-Streit’s slit lamps and the new warranty program, visit